Key result
In STZ-induced diabetic rats, severe hyperlipidemia was associated with a dramatic decline in VLDL-R protein in skeletal muscle and heart, which was restored by insulin in vitro.
The combination of VLDL receptor deficiency and reduced plasma lipoprotein lipase activity may drive severe hyperlipidemia in insulin-deficient diabetes.
Answers are grounded in this paper and cite their sources.
Animal data link VLDL-R loss to diabetic hyperlipidemia; leaves open human relevance and therapeutic implications.
Hyperlipidemia is a common feature of diabetes and is related to cardiovascular disease. The very low-density lipoprotein receptor (VLDL-R) is a member of the low-density lipoprotein receptor (LDL-R) family. It binds and internalizes triglyceride-rich lipoproteins with high specificity. We examined the etiology of hyperlipidemia in the insulin-deficient state. VLDL-R expression in heart and skeletal muscle were measured in rats with streptozotocin (STZ)-induced diabetes. STZ rats showed severe hyperlipidemia on d 21 and 28, with a dramatic decline in VLDL-R protein in skeletal muscle (>90%), heart (approximately 50%) and a loss of adipose tissues itself on d 28. The reduction of VLDL-R protein in skeletal muscle could not be explained simply by a decrease at the transcriptional level, because a dissociation between VLDL-R protein and mRNA expression was observed. The expression of LDL-R and LDL-R-related protein in liver showed no consistent changes. Furthermore, no effect on VLDL-triglyceride production in liver was observed in STZ rats. A decrease in postheparin plasma lipoprotein lipase activity started on d 7 and continued to d 28 at the 50% level even though severe hyperlipidemia was detected only on d 21 and 28. In rat myoblast cells, serum deprivation for 24 h induced a reduction in VLDL-R proteins. Insulin (10(-6) m), but not IGF-I (10 ng/ml), restored the decreased VLDL-R proteins by serum deprivation. These results suggest that the combination of VLDL-R deficiency and reduced plasma lipoprotein lipase activity may be responsible for severe hyperlipidemia in insulin-deficient diabetes.
No takes yet. Share an insight, caveat, or question.
Iwasaki et al. (2005) studied Streptozotocin (STZ)-induced diabetes and hyperlipidemia. Streptozotocin (STZ)-induced diabetes (insulin deficiency) vs. Normal state (implied) was evaluated on VLDL-R expression in heart and skeletal muscle, and hyperlipidemia. In STZ-induced diabetic rats, severe hyperlipidemia was associated with a dramatic decline in VLDL-R protein in skeletal muscle and heart, which was restored by insulin in vitro.
Synapse has enriched 10 related papers. Consider them for comparative context: